BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03729245-completion@plaintrial.com
DTSTAMP:20261027T054409Z
DTSTART;VALUE=DATE:20221019
SUMMARY:A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With
  Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase In
 hibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for A
 dvanced Metastatic Renal Cell Carcinoma (RCC) — estimated completion dat
 e
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT03729245
URL:https://plaintrial.com/trial/NCT03729245
END:VEVENT
END:VCALENDAR